Year-end Report 2020: Scandion Oncology is poised for the future
Scandion Oncology A/S (”Scandion Oncology” or “the Company”) hereby publishes the Year-end Report for the period 1 January – 31 December 2020.Bo Rode Hansen, President & CEO, Scandion Oncology A/S comments: “2020 was undoubtedly a historic year of change in the name of COVID-19 and we all had to accept and adapt to the situation. For Scandion Oncology’s part, we managed to navigate through the crisis in the best possible way, and I can ultimately summarize 2020 as coming out strong for the Company. The Company had 4 major goals for 2020: 1. Initiation of two clinical trials with